Product
CAR-CD19 T Cells
1 clinical trial
2 indications
Indication
B-Cell Non-Hodgkin LymphomaIndication
Relapsed B-cell Non-Hodgkin LymphomaClinical trial
An Open, Multi-center Phase Ⅰ/II Clinical Study to Evaluate the Safety and Efficacy of CT032 Humanized CD19 Autologous Car T Cell Injection in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell LymphomaStatus: Completed, Estimated PCD: 2021-01-20